Response rates and toxicity profile of neoadjuvant immunotherapy in early-stage triple negative breast cancer (TNBC) - Multi institute experience

被引：0
|
作者：
Khalid, F. [1 ]
Attia, M. [2 ]
Mehmood, T. [3 ]
Shah, N. [2 ]
Baki, M. [1 ]
机构：
[1] East & North Hertfordshire NHS Trust, Lister Hosp, Stevenage, England
[2] East & North Hertfordshire, Mt Vernon Canc Ctr, Northwood, England
[3] Univ Hosp Northamptonshire NHS Grp, Kettering, England
来源：
CLINICAL ONCOLOGY | 2025年 / 38卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页数：2
相关论文
共 50 条
  • [21] PROGNOSTIC FACTORS IN EARLY-STAGE TRIPLE NEGATIVE BREAST CANCER (TNBC): THE LIMITS OF CLINICAL AND PATHOLOGICAL FEATURES
    Pecuchet, N.
    Belda, M. Le Frere
    Popovski, T.
    Haouas, S.
    Chamming'S, F.
    Lecuru, F.
    Oudard, S.
    Medioni, J.
    ANNALS OF ONCOLOGY, 2012, 23 : 99 - 99
  • [22] TNBC-DX genomic test in early-stage triple-negative breast cancer treated with neoadjuvant taxane-based therapy
    Martin, M.
    Stecklein, S. R.
    Gluz, O.
    Villacampa, G.
    Monte-Millan, M.
    Nitz, U.
    Cobo, S.
    Christgen, M.
    Braso-Maristany, F.
    Alvarez, E. L.
    Echavarria, I.
    Conte, B.
    Kuemmel, S.
    Bueno-Muino, C.
    Jerez, Y.
    Kates, R.
    Cebollero, M.
    Kolberg-Liedtke, C.
    Bueno, O.
    Garcia-Saenz, J. a.
    Moreno, F.
    Grischke, E. -m.
    Forstbauer, H.
    Braun, M.
    Warm, M.
    Hackmann, J.
    Uleer, C.
    Aktas, B.
    Schumacher, C.
    Wuerstleins, R.
    Graeser, M.
    zu Eulenburg, C.
    Kreipe, H. H.
    Gomez, H.
    Massarrah, T.
    Herrero, B.
    Pare, L.
    Bohn, U.
    Lopez-Tarruella, S.
    Vivanco, A.
    Sanfeliu, E.
    Parker, J. S.
    Perou, C. M.
    Villagrasa, P.
    Prat, A.
    Sharma, P.
    Harbeck, N.
    ANNALS OF ONCOLOGY, 2025, 36 (02) : 158 - 171
  • [23] Outcomes of older adults with early-stage triple-negative breast cancer (TNBC) receiving chemotherapy: a single-institution experience
    Raghavendra, Akshara Singareeka
    Liu, Diane
    Shen, Yu
    Barcenas, Carlos H.
    Ueno, Naoto T.
    Giordano, Sharon
    Tripathy, Debu
    Karuturi, Meghan Sri
    BREAST CANCER RESEARCH AND TREATMENT, 2024, 207 (01) : 81 - 90
  • [24] Neoadjuvant treatments for triple-negative breast cancer (TNBC)
    von Minckwitz, G.
    Martin, M.
    ANNALS OF ONCOLOGY, 2012, 23 : 35 - 39
  • [25] Nodal Positivity in Early-Stage Triple-Negative Breast Cancer: Implications for Preoperative Immunotherapy
    Mittendorf, Elizabeth A.
    Kantor, Olga
    Weiss, Anna
    Richardson, Edward
    Garrido-Castro, Ana
    Portnow, Leah H.
    Krop, Ian E.
    Lin, Nancy U.
    Winer, Eric P.
    Tolaney, Sara M.
    King, Tari A.
    ANNALS OF SURGICAL ONCOLOGY, 2023, 30 (01) : 100 - 106
  • [26] Clinicopathologic Features and Response to Pembrolizumab Neoadjuvant Therapy in Triple Negative Breast Cancer (TNBC): A Single Institution Experience
    Carames, Gian
    Ning, Bohan
    Khoury, Katia
    Wei, Shi
    Xu, Jia
    Guo, Hua
    LABORATORY INVESTIGATION, 2024, 104 (03) : S128 - S129
  • [27] Nodal Positivity in Early-Stage Triple-Negative Breast Cancer: Implications for Preoperative Immunotherapy
    Elizabeth A. Mittendorf
    Olga Kantor
    Anna Weiss
    Edward Richardson
    Ana Garrido-Castro
    Leah H. Portnow
    Ian E. Krop
    Nancy U. Lin
    Eric P. Winer
    Sara M. Tolaney
    Tari A. King
    Annals of Surgical Oncology, 2023, 30 : 100 - 106
  • [28] Pembrolizumab in Early-Stage Triple-Negative Breast Cancer
    Neven, Patrick
    Floris, Giuseppe
    Desmedt, Christine
    NEW ENGLAND JOURNAL OF MEDICINE, 2025, 392 (11):
  • [29] Recurrent Early-Stage Triple-Negative Breast Cancer
    Adonizio, Christian S.
    Grano, Genorosa
    Sharon, Kanu
    Rose, Lewis
    Zibelli, Allison
    Miller-Samuel, Susan
    Morris, Gloria J.
    SEMINARS IN ONCOLOGY, 2010, 37 (05) : 419 - 428
  • [30] TILs in early-stage triple-negative breast cancer
    Artemyeva, A.
    Chuglova, D.
    Kushnarev, V.
    Paltuev, R.
    Demina, N.
    Kudaybergenova, A.
    VIRCHOWS ARCHIV, 2019, 475 : S67 - S67
12345